SCHEMBL3674710

SCHEMBL3674710

CCCCCCCCc1ccc2ccccc2c1-c1c(CCCCCCCC)ccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.47
MAPT P10636 4/20 0.45
KDM4E B2RXH2 5/20 0.44
ALDH1A1 P00352 5/20 0.44
GAA P10253 5/20 0.44
HTT P42858 5/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HPGD P15428 2/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPK1 P28482 1/20 0.44
RAD52 P43351 1/20 0.44
TLR8 Q9NR97 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16671703 0.98 TLR8 (0.45) LIPGMAPTKDM4EALDH1A1GAA
SCHEMBL28091048 0.90 DHFR (0.47) LIPGMAPTKDM4EALDH1A1GAA
SCHEMBL28053356 0.90 DHFR (0.47) LIPGMAPTKDM4EALDH1A1GAA
SCHEMBL28226794 0.90 DHFR (0.47) LIPGMAPTKDM4EALDH1A1GAA
Phosphine SCHEMBL28240083 0.89 DHFR (0.46) LIPGMAPTKDM4EALDH1A1GAA
SCHEMBL7647884 0.89 TYR (0.46) LIPGMAPTKDM4EALDH1A1GAA
SCHEMBL6058808 0.88 DHFR (0.44) LIPGMAPTKDM4EALDH1A1GAA
SCHEMBL4443733 0.86 MAPT (0.42) LIPGMAPTKDM4EALDH1A1GAA
SCHEMBL236078 0.84 TYR (0.47) LIPGMAPTKDM4EALDH1A1GAA
SCHEMBL11381159 0.84 TYR (0.47) LIPGMAPTKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831326-B1 ELECTROLUMINESCENT POLYMERS AND THEIR USE MERCK PATENT GMBH (DE) 2017-03-01 EP disclosed
EP-1831326-B1 ELECTROLUMINESCENT POLYMERS AND THEIR USE MERCK PATENT GMBH (DE) 2017-03-01 EP disclosed
US-20100108989-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF MERCK PATENT GMBH (DE) 2010-05-06 US disclosed
EP-1831326-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF Merck Patent GmbH (DE) 2007-09-12 EP disclosed
WO-2006063852-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF MERCK PATENT GMBH (DE) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108989-A1 ELECTROLUMINESCENT POLYMERS AND USE THEREOF MAP1LC3C, EPCAM, MAP1LC3A LIPG 1345/4885MAPT 264/4885KDM4E 3892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.